Robert Alexander Ingram - Nov 30, 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Nov 30, 2022
Transactions value $
$20,000
Form type
4
Date filed
12/2/2022, 05:24 PM
Previous filing
Sep 19, 2022
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Award $20K +1.5K +1.55% $13.36 97.9K Nov 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $20,000.